ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

Consolidation Unlikely to Save Money

December 17, 2010

Breast Cancer: Pitt “Regrets” Any Harm, Expresses Pride In Fisher’s Work

September 5, 1997

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008

Transplant Is Viable Option For HIV+ Patients, Study Finds

February 25, 2005

Budget Process for FY ’81 Starts; Investigators Initiated Definition May Be Heated Issues

August 31, 1979

DCT Board Says RDOG Concept Too Expensive; Discusses Grant Funding

July 24, 1992